Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 225, Issue 1-2, 2010, Pages 52-61

  Sinha, Sushmita ^a,b   Miller, Lisa ^a   Subramanian, Sandhya ^a   McCarty, Owen J T ^c   Proctor, Thomas ^a,d   Meza Romero, Roberto ^a,b,d   Huan, Jianya ^b,d   Burrows, Gregory G ^b,d   Vandenbark, Arthur A ^a,b,d   Offner, Halina ^a,b,d  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Oregon Health and Science University Department of Biomedical Engineering   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

APCs; EAE; RTLs; Tolerance

Indexed keywords

CD11B ANTIGEN; RTL 401; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; FEMALE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD11B; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; LIGANDS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOCYTES; MYELIN PROTEOLIPID PROTEIN; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 77955653379     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.04.013     Document Type: Article

References (23)

1. Bauer J., Huitinga I., Zhao W., Lassmann H., Hickey W.F., Dijkstra C.D. The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia 1995, 15:437-446.
2. Benveniste E.N. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 1997, 75:165-173.
3. Bullard D.C., Hu X., Schoeb T.R., Axtell R.C., Raman C., Barnum S.R. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J. Immunol. 2005, 175:6327-6333.
4. Burrows G.G., Bebo B.F., Adlard K.L., Vandenbark A.A., Offner H. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis. J. Immunol. 1998, 161:5987-5996.
5. Burrows G.G., Chang J.W., Bachinger H.P., Bourdette D.N., Offner H., Vandenbark A.A. Design, engineering and production of functional single-chain T cell receptor ligands. Protein Eng. 1999, 12:771-778.
6. Burrows G.G., Chou Y.K., Wang C., Chang J.W., Finn T.P., Culbertson N.E., Kim J., Bourdette D.N., Lewinsohn D.A., Lewinsohn D.M., Ikeda M., Yoshioka T., Allen C.N., Offner H., Vandenbark A.A. Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells. J. Immunol. 2001, 167:4386-4395.
7. Chou Y.K., Culbertson N., Rich C., LaTocha D., Buenafe A.C., Huan J., Link J., Wands J.M., Born W.K., Offner H., Bourdette D.N., Burrows G.G., Vandenbark A.A. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice. J. Neurosci. Res. 2004, 77:670-680.
8. Davis M.M., Boniface J.J., Reich Z., Lyons D., Hampl J., Arden B., Chien Y. Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 1998, 16:523-544.
9. Gordon E.J., Myers K.J., Dougherty J.P., Rosen H., Ron Y. Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 1995, 62:153-160.
10. Huan J., Subramanian S., Jones R., Rich C., Link J., Mooney J., Bourdette D.N., Vandenbark A.A., Burrows G.G., Offner H. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch. J. Immunol. 2004, 172:4556-4566.
11. Link J. Partial MHC class II molecules preferentially bind to B cells. J. Immunol. 2007, 78.
12. Link J.M., Rich C.M., Korat M., Burrows G.G., Offner H., Vandenbark A.A. Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice. Clin. Immunol. 2007, 123:95-104.
13. Nicholson G.C., Tennant R.C., Carpenter D.C., Sarau H.M., Kon O.M., Barnes P.J., Salmon M., Vessey R.S., Tal-Singer R., Hansel T.T. A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist. Pulm. Pharmacol. Ther. 2007, 20:52-59.
14. Offner H., Subramanian S., Wang C., Afentoulis M., Vandenbark A.A., Huan J., Burrows G.G. Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury. J. Immunol. 2005, 175:4103-4111.
15. Offner H., Sinha S., Wang C., Burrows G.G., Vandenbark A.A. Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis. Rev. Neurosci. 2008, 19:327-339.
16. Rubel C., Miliani De Marval P., Vermeulen M., Isturiz M.A., Palermo M.S. Lipopolysaccharide enhances FcgammaR-dependent functions in vivo through CD11b/CD18 up-regulation. Immunology 1999, 97:429-437.
17. Sinha S., Subramanian S., Proctor T.M., Kaler L.J., Grafe M., Dahan R., Huan J., Vandenbark A.A., Burrows G.G., Offner H. A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS. J. Neurosci. 2007, 27:12531-12539.
18. Sinha S., Subramanian S., Miller L., Proctor T.M., Roberts C., Burrows G.G., Vandenbark A.A., Offner H. Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand. J. Neurosci. 2009, 29:3816-3823.
19. Sinha S., Subramanian S., Emerson-Webber A., Lindner M., Burrows G.G., Grafe M., Linington C., Vandenbark A.A., Bernard C.C., Offner H. Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG. J. Neuroimmune. Pharmacol. 2010, 5:231-240.
20. Vandenbark A.A., Rich C., Mooney J., Zamora A., Wang C., Huan J., Fugger L., Offner H., Jones R., Burrows G.G. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice. J. Immunol. 2003, 171:127-133.
21. Wang C., Mooney J.L., Meza-Romero R., Chou Y.K., Huan J., Vandenbark A.A., Offner H., Burrows G.G. Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation. J. Immunol. 2003, 171:1934-1940.
22. Wang C., Gold B.G., Kaler L.J., Yu X., Afentoulis M.E., Burrows G.G., Vandenbark A.A., Bourdette D.N., Offner H. Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE. J. Neurochem. 2006, 98:1817-1827.
23. Yadav V., Bourdette D., Bowen J.D., Lynch S.G., Mattson D., Preinigerova J., Rose C., Stead R.B., Ferro A.J., Goldstein A.S., Burrows G., Offner H., Vandenbark A. Recombinant T cell receptor ligand (RTL) for the treatment of multiple sclerosis: report of a phase I clinical trial. Neurology 2010, 74(S2):A293-A294.